Cannabis and Sleep Apnea
What research shows about cannabinoids for obstructive sleep apnea and airway obstruction.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
Dronabinol, a synthetic THC pill, showed modest AHI reductions in small, short trials—but even the American Academy of Sleep Medicine recommends against it for OSA. Smoked cannabis has no supporting evidence and carries a real risk of worsening airway collapse. CPAP, weight loss, and mandibular devices work far better. If you have sleep apnea, cannabis is not a substitute.
Medical disclaimer
This article summarizes published research and clinical guidelines. It is not a substitute for evaluation by a sleep physician. Untreated obstructive sleep apnea raises your risk of heart attack, stroke, and fatal car crashes. If you suspect you have sleep apnea—loud snoring, witnessed pauses in breathing, daytime sleepiness—get a sleep study. Do not use this article to delay diagnosis or replace evidence-based treatment like CPAP.
Plain-language summary
Obstructive sleep apnea (OSA) is a condition where the muscles of your upper airway relax too much during sleep, blocking airflow. You stop breathing for seconds at a time, dozens or hundreds of times a night, and your oxygen drops. The standard treatment is CPAP (continuous positive airway pressure), which physically holds the airway open with pressurized air Strong evidence[1].
Researchers have looked at cannabinoids for OSA because THC affects serotonin signaling, which in turn affects the muscles of the upper airway. A small number of trials tested dronabinol—a synthetic THC pill, FDA-approved for nausea and appetite, not for sleep apnea—and showed modest reductions in the apnea-hypopnea index (AHI), a measure of breathing interruptions per hour Weak / limited[2][3]. No trial has shown that smoked or vaped cannabis improves sleep apnea. The American Academy of Sleep Medicine reviewed the evidence in 2018 and explicitly recommended against using medical cannabis or synthetic cannabis extracts to treat OSA, citing weak evidence, unknown long-term effects, and variable cannabis composition Strong evidence[4].
What probably works for OSA (not cannabis)
No cannabis formulation meets a 'probably works' bar for sleep apnea No data. Here is what does work:
- CPAP reduces AHI by 80–95% in most patients and improves daytime sleepiness, blood pressure, and quality of life Strong evidence[1].
- Weight loss of 10% or more substantially reduces AHI in patients with obesity-related OSA Strong evidence[5].
- Mandibular advancement devices reduce AHI by 40–60% for mild-to-moderate OSA Strong evidence[1].
- Hypoglossal nerve stimulation (Inspire) reduces AHI by roughly 50–70% in CPAP-intolerant patients Strong evidence[1].
If you are hoping cannabis can replace one of these: current evidence says it cannot.
Dronabinol: weak evidence from small trials
Dronabinol (synthetic THC) is the only cannabinoid tested in controlled trials for OSA. Two small proof-of-concept trials by Carley and colleagues at the University of Illinois tested dronabinol in adults with moderate-to-severe OSA Weak / limited[2][3].
In the phase II PACE trial (n=73), dronabinol 2.5–10 mg taken before bed reduced AHI by roughly 33% compared to placebo over six weeks, and patients reported improved subjective sleepiness Weak / limited[2]. The mechanism is unclear but may involve serotonergic effects on upper airway muscle tone.
Why this is classified as weak evidence:
- Only ~73 subjects total across published trials.
- Short duration (6 weeks). OSA is a lifelong condition; no long-term data exist.
- The AHI reduction, while statistically significant, did not bring most patients to a non-apneic range—they still had clinically significant OSA.
- No replication by an independent research group.
- No data on cardiovascular outcomes (heart attack, stroke, hypertension), which are the actual clinical endpoints that matter in OSA.
- No dose optimization or head-to-head comparison with standard treatments.
The American Academy of Sleep Medicine explicitly reviewed these trials and recommended against clinical use, stating the evidence was insufficient Strong evidence[4].
What does not work or lacks evidence
Smoked or vaped cannabis flower. Zero controlled trials test whether whole-plant cannabis improves AHI, oxygen saturation, or daytime sleepiness in OSA patients No data. This is a significant gap: whole-plant cannabis is what most people use, not synthetic dronabinol.
CBD. No controlled trials have tested CBD as a treatment for sleep apnea No data. CBD's effects on sleep in healthy people are mixed and dose-dependent Weak / limited[6].
Cannabis for snoring. Snoring folklore pervades cannabis culture, but there is no evidence Anecdote. Alcohol and cannabis are both upper-airway muscle relaxants. There is a reasonable mechanistic concern that inhaled cannabis at bedtime could worsen upper airway collapsibility, particularly in people who already have OSA Weak / limited.
'Indica' strains for sleep apnea. The indica/sativa distinction does not reliably predict effects or cannabinoid composition Strong evidence[7]. Even if strain names were meaningful, sedation is not the same as treating apnea. A person who is more deeply sedated but still not breathing has not been helped—they may simply be less arousable, which in severe OSA is dangerous.
What we don't know
- Whether dronabinol's effect persists beyond 6 weeks, or whether tolerance develops with chronic use.
- Whether any cannabinoid reduces the cardiovascular complications of OSA (heart attack, stroke, hypertension—the outcomes that actually determine mortality).
- Whether cannabis worsens, improves, or has no effect on central sleep apnea (where the brain fails to signal breathing, as opposed to airway obstruction). There is theoretical concern that cannabis could suppress respiratory drive, but no empirical data exist.
- Whether chronic cannabis use changes sleep architecture in ways that interact with OSA. REM rebound after withdrawal, for example, could increase apneas, since most obstructive events occur in REM sleep.
- What dose, formulation, or cannabinoid ratio—if any—would be optimal for any patient subgroup.
- Whether cannabis worsens compliance with evidence-based treatments.
Risks of using cannabis if you have sleep apnea
Upper airway muscle relaxation. THC, like alcohol and benzodiazepines, can relax the muscles that keep your airway open. In people with OSA, this is the opposite of therapeutic Weak / limited. The upper airway collapse problem is already your main issue.
Reduced arousal from apneic events. Sedatives blunt the brain's ability to wake you up when oxygen drops. Cannabis is sedating. In OSA, arousal from an apneic event is protective—it restores breathing. Blunting arousal is a theoretical but plausible harm Weak / limited.
Smoking-related airway inflammation. Combusted cannabis irritates the upper and lower airways Strong evidence[8], which is not helpful in a disease defined by airway dysfunction.
Delayed or missed diagnosis. Using cannabis to feel like you slept better can mask symptoms (daytime sleepiness, unrefreshing sleep) and delay a sleep study, allowing OSA to cause organ damage.
CPAP avoidance. Some patients report using cannabis instead of CPAP. This is the worst possible substitution: a treatment with strong evidence replaced by one with none.
How cannabis compares to standard treatments
| Treatment | Typical AHI reduction | Evidence quality | Notes |
|---|---|---|---|
| CPAP | 80–95% (near-normal) | Strong [1] | First-line; adherence is the main challenge |
| Mandibular advancement device | 40–60% | Strong [1] | Best for mild–moderate OSA |
| Weight loss (≥10%) | 25–50% | Strong [5] | Durable if weight is maintained |
| Hypoglossal nerve stimulation (Inspire) | 50–70% | Strong [1] | For CPAP-intolerant moderate–severe OSA |
| Dronabinol (synthetic THC) | ~33% (6-week data only) | Weak [2][3] | Not FDA-approved for OSA; AASM recommends against |
| Smoked/vaped cannabis | Unknown; possible worsening | None No data | May worsen airway collapsibility |
Dronabinol is the worst-performing intervention on this list and also the least studied. There is no clinical scenario in which it should be a first-line choice.
Bottom line for patients
If you have obstructive sleep apnea:
- Start with CPAP, weight loss, or a mandibular device. These have strong evidence and proven cardiovascular benefit.
- Do not use cannabis as a treatment or substitute. The evidence does not support it, and the mechanism raises harm concerns.
- If you use cannabis for other reasons, tell your sleep physician. They need to know, especially if you are considering starting CPAP.
- Understand the difference between sedation and treatment. Feeling sleepier at night is not the same as breathing better.
- Get a sleep study if you have symptoms. Untreated sleep apnea causes heart attacks and strokes. Do not delay diagnosis.
Sources
- Peer-reviewed Patil SP, Ayappa IA, Caples SM, et al. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2019;15(2):335-343.
- Peer-reviewed Carley DW, Prasad B, Reid KJ, et al. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. Sleep. 2018;41(1):zsx184.
- Peer-reviewed Prasad B, Radulovacki MG, Carley DW. Proof of concept trial of dronabinol in obstructive sleep apnea. Frontiers in Psychiatry. 2013;4:1.
- Peer-reviewed Ramar K, Rosen IM, Kirsch DB, et al. Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement. Journal of Clinical Sleep Medicine. 2018;14(4):679-681.
- Peer-reviewed Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes (Sleep AHEAD). Archives of Internal Medicine. 2009;169(17):1619-1626.
- Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports. 2017;19(4):23.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLoS One. 2022;17(5):e0267498.
- Peer-reviewed Tashkin DP. Effects of marijuana smoking on the lung. Annals of the American Thoracic Society. 2013;10(3):239-247.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and REM Sleep — THC reduces REM sleep reliably; stopping causes vivid rebound dreams. Evidence for other u...
- Cannabis and Sleep Architecture — How cannabinoids alter sleep stages, what works short-term, why tolerance develops, and sa...
- Cannabis and Stroke Risk — Cannabis use is associated with elevated stroke risk, especially in younger adults and wit...
- Cannabis and Sleep — Evidence-based overview of cannabis, THC, and CBD for sleep onset and insomnia.
- Cannabis Tolerance and Sleep Effects — Short-term sedation, tolerance, rebound insomnia, and why long-term use often backfires.
- Cannabis Withdrawal and Sleep Disruption — Sleep disruption is a hallmark of cannabis withdrawal syndrome and typically resolves with...
- Sleep-promoting strain — A retail marketing category for cannabis sold as sleep-inducing, without clinical validati...